We tested the hypothesis that progesterone (P 4 ) acts at a local level to inhibit luteal apoptosis. Initial experiments employed aminoglutethimide, a P450 cholesterol side-chain cleavage inhibitor, to inhibit steroid synthesis. Cultured bovine luteal cells were treated with aminoglutethimide (0.15 mM) ؎ P 4 (500 ng/ ml) for 48 h. Luteal cells were recovered and snap frozen for isolation and analysis of oligonucleosomal DNA fragmentation or fixed for morphological analysis. Medium was collected for analysis of P 4 levels by RIA. Aminoglutethimide inhibited P 4 synthesis by Ͼ 95% and increased the level of apoptosis as evidenced by 32 P-labeled oligonucleosomal DNA fragmentation (Ͼ 40%). P 4 supplementation inhibited the onset of apoptosis that was induced by aminoglutethimide. These data were further supported by morphological assessment of apoptotic cells utilizing a Hoechst staining technique and together strongly suggest that P 4 has anti-apoptotic capacity. Using reverse transcription-polymerase chain reaction, we were able to isolate a 380-base pair cDNA from the bovine corpus luteum (CL) that was 100% homologous to the progesterone receptor (PR) previously found in bovine oviductal tissue. Furthermore, PR transcripts were present in large and small luteal cells. Immunohistochemistry also revealed that PR protein was present in both large and small luteal cells. To determine whether the anti-apoptotic effect of P 4 was regulated at the receptor level, luteal cells were cultured in the presence of PR antagonists, RU-486 and onapristone, for 48 h. Both antagonists caused approximately a 40% increase in 32 Plabeled oligonucleosomal DNA fragmentation. Interestingly, there was no difference (P Ն 0.05) in P 4 levels after treatment with PR antagonists. These observations support the concept that P 4 represses the onset of apoptosis in the CL by a PR-dependent mechanism.
INTRODUCTION
The corpus luteum (CL) is a transient endocrine organ that synthesizes progesterone (P 4 ) in support of the developing embryo. Aside from the traditional P 4 target tissues (uterus and mammary gland) [1] [2] [3] , the CL also may be a site of P 4 action [4] [5] [6] [7] [8] [9] . Luteal-derived P 4 has been implicated as a luteotropin [10] and may have some anti-apoptotic activity [11] . Furthermore, progesterone receptor (PR) mRNA and protein are present in the primate CL, suggesting that P 4 may have direct effects on luteal function [6, 7, 9, [12] [13] [14] . In addition, there is mounting evidence suggesting that P 4 can regulate granulosa cell proliferation [15] , influence steroid synthesis [13, 16] , alter prostaglandin levels [17] , and inhibit apoptosis in a variety of PR-positive tissues including those of the ovary [18] [19] [20] . Thus, P 4 -producing cells may have the potential to regulate their own fate; however, the exact signaling mechanisms involved have not been elucidated and may be unique to specific species.
Apoptosis, a significant component of luteal regression, has been described by morphological and biochemical parameters in many domestic species including the pig [21] , sheep [22] [23] [24] , and cow [25] [26] [27] . In the ovine and bovine CL, the appearance of internucleosomal fragmentation of DNA (laddering) characteristic of apoptosis is associated with natural as well as PGF 2␣ -induced luteolysis [23, 25] . Of considerable interest are the observations that the onset of apoptosis is not evident until P 4 levels have declined [23, 25] . Whether or not the decline in P 4 levels is sufficient to initiate apoptosis in the luteal cells is not known. Furthermore, the presence of specific PR and their blockade by specific PR antagonists in bovine luteal tissue have not been demonstrated. The demonstration of direct effects of P 4 on ovarian cells would implicate locally produced P 4 as an autocrine factor. It is possible, however, that P 4 signaling may not occur as a result of its interaction with the classical PR [28] . Recent experiments in the rat have failed to find PR mRNA in the CL and suggest that in the absence of a PR, P 4 may be signaling by either a gamma aminobutyric acid-like receptor [28] or even the glucocorticoid receptor [29] .
We hypothesize that P 4 signaling through the classical PR regulates the function of the bovine CL. Furthermore, the inhibition of P 4 synthesis associated with functional luteal regression may play an important role in the acceleration of structural regression of the CL. The studies presented demonstrate that 1) inhibition of steroid synthesis and removal of P 4 accelerated the onset of apoptosis, 2) luteal cells express mRNA and protein for PR, and importantly, 3) specific PR antagonists accelerated apoptotic cell death.
MATERIALS AND METHODS

Animal Model
CL from cows were obtained from a local slaughter facility in accordance with protocols approved by the local FIG. 1. Aminoglutethimide effects on steroid synthesis. Shown are levels of P 4 in media after treatment of dissociated luteal cells with increasing dosages of aminoglutethimide. The cells were subjected to an initial treatment of aminoglutethimide in fresh medium for 2 h; the medium was then removed and replaced with fresh aminoglutethimide to remove any residual P 4 and cultured for 24 h. At the end of the culture period, medium was removed and assayed for P 4 institutional animal care and use committee. Bovine CL from early pregnancy (2-3 mo based on fetal crown rump length; Ͻ 30 cm) were collected from a local slaughterhouse and transported back to the laboratory in cold medium 199. CL were dispersed with collagenase as previously described [30] . Luteal cells (10 5 /cm 2 ) were incubated in medium 199 (M199; supplemented with 0.1% BSA, 25 mM Hepes, and 25 mM NaHCO 3 ) containing 5% fetal calf serum (FCS) overnight in an atmosphere of humidified air with 5% CO 2 at 37ЊC. Cells were allowed to attach to cell culture flasks and/or dishes (Falcon 6-well or 25-cm 2 flasks; Fisher, St. Louis, MO) for at least 24 h. After the initial incubation period, medium was replaced with fresh serumfree medium (supplemented with 0.1% BSA and 5 g/ml bovine insulin) and incubated for an additional 18 h to allow stabilization of the cells prior to the initiation of treatments.
Inhibition of Steroid Synthesis
Aminoglutethimide, a P450 cholesterol side-chain cleavage inhibitor, was dissolved in dimethyl sulfoxide (DMSO) and added in increasing amounts (up to 0.2 mM) to determine the effective concentrations that inhibit P 4 synthesis. The final concentration of DMSO never exceeded 0.05%. The controls received DMSO alone. Results from our preliminary studies demonstrated that treatment with aminoglutethimide produced concentration-dependent inhibition of P 4 production (Fig. 1) . On the basis of these results, 0.15 mM aminoglutethimide, which completely blocked P 4 synthesis, was employed in subsequent experiments. Concentrations of aminoglutethimide in our studies were similar to those used in previous studies of rat granulosa cells in ovarian tissue cultures and shown not to result in acute cell death [31] . To ensure P 4 depletion, cultures were treated with the steroid inhibitor for 2 h and then washed two times to remove any endogenously accumulated P 4 . Fresh media and aminoglutethimide were added back, and the cultures were continued for 48 h. At the end of the incubation period, the medium was collected and frozen immediately for hormone analysis. The cells were scraped, quick frozen, and stored until genomic DNA could be isolated.
P 4 Replacement
To rule out possible nonspecific effects of aminoglutethimide, we evaluated whether or not exogenous P 4 could reverse the effects of aminoglutethimide. To accomplish this, bovine luteal cell cultures prepared as described above were treated with or without (vehicle alone) aminoglutethimide (0.15 mM) Ϯ supplemental P 4 (500 ng/ml; dissolved in ethyl alcohol [EtOH] ) for 48 h. The final concentration of EtOH was equivalent to 0.05%. At the end of the incubation period the medium was aspirated and frozen immediately for steroid analysis. The cells were scraped, collected, quick frozen, and stored until genomic DNA could be isolated.
Morphological Assessment of Apoptosis
To support the initial experiment, which demonstrated an increased amount of oligonucleosomal DNA laddering, a second experiment was performed utilizing the Hoechst staining technique that distinguishes apoptotic cells on the basis of nuclear condensation, nuclear morphology, and increased fluorescence. To accomplish this, CL were dispersed with collagenase as previously described [30] . Prior to plating, culture dishes were pretreated with 10% FCS in M199 for 1 h. The medium was aspirated, and the dishes were rinsed twice with M199. Luteal cells (10 5 /cm 2 ) were incubated in M199 (supplemented with 0.1% BSA, 25 mM Hepes, and 25 mM NaHCO 3 ) containing 5 g/ml insulin, 5 g/ml transferrin, and 5 ng/ml selenium (ITS; Beckton Dickinson, Bedford, MA) in an atmosphere of humidified air with 5% CO 2 at 37ЊC. Cells were allowed to attach to the six-well plates (Falcon; Fisher) for at least 24 h. After the initial incubation period, medium was replaced with fresh serum-free medium (supplemented with 0.1% BSA and ITS). Treatments were the same as described for the initial experiment in which steroid production was inhibited by the addition of 0.15 mM aminoglutethimide with or without P 4 and compared to that in the control (vehicle treated) cultures. After the 48-h treatment period the medium was removed; cells were rinsed once, fixed in icecold methyl alcohol, and allowed to air dry. The nuclei were stained with Hoechst 33258 dye (Sigma Chemical Co., St. Louis, MO) (0.5 g/ml in PBS) for 2 min. The dye was aspirated and the dishes were rinsed four times with PBS (5 min each). Treatment effects were determined by counting the number of apoptotic cells and calculating them as a percentage of the total in a single field. Five different fields were assessed in each well. To eliminate any biases, counts were made by two different individuals and compared in order to confirm the accuracy of counting apoptotic and non-apoptotic positive cells.
Isolation of Bovine Luteal PR cDNA
Experiments were performed to determine whether the PR gene was expressed at the RNA level in the bovine
The effect of exogenous P 4 on the onset of aminoglutethimideinduced apoptosis. Dissociated bovine luteal cells were cultured in the presence or absence of aminoglutethimide Ϯ P 4 (500 ng/ml). After 48 h, the cells were harvested, and genomic DNA was isolated and analyzed for oligonucleosomal DNA fragmentation as a marker for apoptosis. A) The graph represents the quantitative measurement of low molecular weight labeling (Ͻ 15 kb) as a percentage of control (vehicle-treated cells). The * represents significance at the P Ͻ 0.05 level. There were a minimum of 3 separate experiments for each (n Ն 3). B) A qualitative example of low molecular weight labeling after treatment with or without aminoglutethimide in the presence or absence of P 4 (500 ng/ml).
CL. Total RNA was isolated from bovine CL collected from cows during the midluteal phase (n ϭ 3) and early pregnancy (n Ͼ 3), as well as from the uterus, spleen, heart, and kidney. In addition, dissociated bovine luteal cells originating from CL collected from cows in early pregnancy (n ϭ 3) were subjected to centrifugal elutriation in order to obtain relatively pure fractions of large and small luteal cells [32] . Upon separation, the enriched luteal cell fractions were subjected to RNA isolation [33] . Total RNA was isolated from bovine tissues and cells and reverse transcribed (5 g/reaction) into first-strand cDNA using random hexamer primers (Boehringer-Mannheim, Indianapolis, IN), oligo(dT) primers (Promega, Madision, WI), and avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI). Oligonucleotide primers were synthesized (sense 5Ј ccgtaagccagagaatcactt 3Ј and antisense 5Ј ttatgatgactccttcatccgc 3Ј) on the basis of the bovine PR sequence obtained from oviductal tissue (accession no. Z86041) and were used for polymerase chain reaction (PCR) amplification of the corresponding bovine luteal cDNA sequences as follows. The first-strand cDNA was subjected to 35 cycles of PCR amplification using the primer set (1-min denaturation at 94ЊC, 1-min annealing at 50ЊC, and 2-min extension at 72ЊC). Amplified products derived from the bovine tissues were resolved in 2% agarose gels and stained with ethidium bromide. After visualization, the amplified product derived from the bovine CL was isolated and subcloned into pGEMT vector for large-scale plasmid preparation and automated DNA sequence analysis performed at the University of Kansas School of Medicine core facility.
Immunohistochemical Analysis of PR
For immunocytochemical studies, the CL from mature heifers were collected by transvaginal lutectomy on Day 8 of the estrous cycle (Day 0: onset of estrus; n ϭ 2). Fresh luteal tissue was mounted in Tissue-Tek II OCT (Miles Inc., Elkhart, IN) and frozen in liquid nitrogen. Immunocytochemistry of PR was performed on microwave-stabilized tissue sections as recently described for estrogen receptor [34] . Cryostat sections (5 m) were prepared on a Hacker/Bright cryostat (Fairfield, NJ), thaw mounted on gelatin-coated glass slides, placed on ice at 4ЊC, microwaved for 2 sec, and lightly fixed (0.2% picric acid, 2% paraformaldehyde in PBS) for 10 min. After fixation, slides were rinsed (0-4ЊC), first with PBS containing 1.5% (w:v) polyvinyl-pyrrolidine (PVP; M r 360,000; Sigma) and 0.075% (v:v) Brij-35 (Sigma); then PBS with 1.5% PVP and 0.37% (w:v) glycine (Sigma); and lastly 1.5% PVP and 0.1% (w:v) gelatin in PBS. Slides were then treated for 20 min with a nonspecific serum (goat) and next incubated overnight at 0-4ЊC with the monoclonal anti-PR antibody (JZB-39; 1 g/ml; provided by Geoffrey Greene, University of Chicago, Chicago, IL). This antibody recognizes the A and B isoforms of the human PR. As a control for nonspecific staining by antibodies of the same subtype as JZB-39 (IgG2 a ), we substituted a monoclonal antibody directed against an antigen of timothy pollen (AT; 10 g/ml; provided by Dr. Arthur Malley, Oregon Regional Primate Research Center, Beaverton, OR). After incubation, the primary antibody was subjected to reaction with an anti-rat IgG biotinylated second antibody and detected with an avidin-biotin peroxidase kit (Vector Laboratories, Burlingame, CA). Tissue sections were then lightly counterstained with hematoxylin. Photomicrographs of immunocytochemical preparations were captured with an Optronics DEI-750T digital camera (Goleta, CA) through Zeiss planapochromatic lenses (New York, NY) and printed with a Sony Mavigraph dye sublimation printer (Tokyo, Japan).
Treatment with PR Antagonists
To determine whether endogenous P 4 exerted its protective effects via the classical receptor level, dissociated luteal cells were treated with two well-characterized PR antagonists, RU-486 (0.05 M; Roussel-Uclaf, Romainville, France) and onapristone (5 M; Schering, Berlin, Germany). RU-486 and onapristone were dissolved in EtOH; the final concentration of EtOH did not exceed 0.05% and 0.01%, respectively. The appropriate vehicle was added to each of the controls. These experiments were performed in the presence of endogenous P 4 . At the completion of the 48-h incubation period, the medium was removed and saved for hormone analysis. The cells were scraped, transferred to an Eppendorf (Hamburg, Germany) tube, pelleted by centrifugation, quick frozen, and stored until processed.
RIAs
Medium was collected at the termination of all experiments and stored at Ϫ20ЊC for steroid analysis. RIA of P 4 was performed in accordance with standard procedures in our laboratory [30] .
Extraction of DNA and Analysis
Genomic DNA was prepared as previously described and analyzed for its integrity [35] . The quantity and purity of nucleic acid preparations were estimated by measuring the optical density of each sample (A260/A280). An equivalent amount of genomic DNA (1 g) from each treatment group was radiolabeled on 3Ј ends with [␣ -FIG. 3 . Identification of apoptotic cells after treatment with or without aminoglutethimide or vehicle in the presence or absence of exogenous P 4 . Dissociated bovine luteal cells were cultured in the presence or absence of aminoglutethimide Ϯ P 4 (500 ng/ml). A) After 48 h, the cells were fixed, and the genomic DNA was stained with Hoescht dye (0.5 g/ml of PBS) as described in the text. The plates were analyzed
. B)
The graph represents the quantitative measurement of apoptotic cells as a percentage of total cells counted. The * represents significance at the P Ͻ 0.05 level. There were 3 separate experiments (n ϭ 3).
32 P]dideoxy-ATP (3000 Ci/mmol; Amersham; now Amersham Pharmacia Biotech, Piscataway, NJ) using terminal transferase (25 U, Boehringer-Mannheim). Labeled DNA samples were separated by electrophoresis through 2% agarose gels (500 ng of labeled DNA per well) for approximately 3.5 h at 65 V. Gels were dried without heat in a slab dryer and exposed to film (X-Omat films at Ϫ70ЊC; Eastman Kodak, Rochester, NY) for autoradiographic analysis. To provide a quantitative estimate of the degree of DNA cleavage among samples, low molecular weight DNA (Ͻ 15 kilobases) was excised from the gel, mixed with 3 ml of scintillation fluid (Scintverse BD; Fisher Scientific, Pittsburgh, PA), and counted in a beta counter as previously described [26] .
Elutriation
Collagenase-dissociated cells (100 ϫ 10 6 ) were resuspended and subjected to centrifugal elutriation using elutriation medium (Ca 2ϩ /Mg 2ϩ -free Dulbecco's modified Eagle's medium, pH 7.2, 25 mM Hepes, antibiotics, 0.1% BSA, and 0.02 mg/ml deoxyribonuclease) in a Beckman (Palo Alto, CA) J6B centrifuge as previously described [32] . The luteal cells were injected into an elutriation cham-FIG. 4 . Isolation of partial cDNA encoding PR from bovine tissues. Photographs of RT-PCR products electrophoresed through a 2% agarose gel and stained with ethidium bromide. The RT was performed using total RNA derived from various bovine tissues, including A) luteal tissue from pregnant (P) and nonpregnant (NP) cows and specific steroidogenic cell fractions (large luteal cells and small luteal cells: LLC and SLC, respectively) in comparison to spleen (S) and control (C; no DNA); and B) spleen (s), ovary (ov), lung (lg), uterus (ut), kidney (k), and heart (ht) (C: control lane [no DNA]).
ber, and the eluates were collected with continuous flow as follows. A 200-ml fraction containing predominantly erythrocytes and endothelial cells (Ͻ 10 m) and a variable degree of small luteal cells was harvested using a flow rate of 16 ml/min at 1800 rpm. A second 200-ml fraction containing predominantly small luteal cells (10-20 m) was harvested using a flow rate of 16 ml/min at 1400 rpm. A third fraction containing small cell clumps mixed with large cells was collected using a flow rate of 24 ml/min at 1200 rpm. The remaining fraction of highly enriched large cells (Ͻ 30 m), containing less than 5% enucleated cells, was collected using a flow rate of 30 ml/min at 680 rpm. The yield and viability of cells in each fraction were exactly as reported in a previous investigation of large and small luteal cell-specific expression of prostaglandin F 2␣ and LH receptors [32] . The same elutriated cell fractions (n ϭ 3) were used in this study for the purpose of generating cDNA for the isolation of a PR fragment.
RNA Isolation
Total RNA was isolated by the guanidine isothiocyanatephenol-chloroform extraction procedure [33] as described previously [23] . The purity and quantity of RNA was estimated by measuring the optical density of each sample (A260/A280).
Data Analysis and Presentation
All experiments were repeated at least three times with cell preparations prepared from separate animals for each experiment. A representative autoradiogram provides qualitative presentation of internucleosomal DNA laddering, whereas the results of the quantitative analysis are presented in graph form. The quantitative results represent the mean Ϯ SEM of combined data from replicated experiments. Statistical differences were determined by one-way ANOVA followed by Scheffe's test. Significance was assigned at P Ͻ 0.05.
RESULTS
P 4 Synthesis Inhibition and P 4 Supplementation
Aminoglutethimide treatment of luteal cells inhibited the synthesis of P 4 in a concentration-dependent manner (Fig.  1) . Based on 3Ј end-labeling of the DNA, levels of apoptosis were elevated (P Ͻ 0.05) with the addition of aminoglutethimide for 48 h. Therefore, a second experiment was designed to confirm the specificity of aminoglutethimide and to determine whether P 4 had anti-apoptotic capacity. Supplementation with P 4 (500 ng/ml) in the presence of the steroid inhibitor blocked (P Ͻ 0.05) the apoptosis induced by aminoglutethimide (Fig. 2) .
Morphological Assessment of Apoptotic Cells and Cell Numbers
Similar to our results obtained in the previous experiment utilizing the 3Ј end-labeling technique, the numbers of apoptotic cells were increased (P Ͻ 0.001) after the inhibition of steroid synthesis as determined by the Hoechst staining technique (Fig. 3) . In agreement with results from the previous experiment, the addition of P 4 to the aminoglutethimide-treated cell cultures abrogated (P Ͻ 0.001) the increase in the number of apoptotic cells observed in those cultures treated with aminoglutethimide alone. There was no difference (P Ͼ 0.05) in the number of apoptotic cells in the P 4 -treated as compared to the control (vehicle-treated) cell cultures, nor were there any differences between the control (vehicle-treated) and the aminoglutethimide ϩ P 4 groups. It is of interest to recognize that there was a range of 5-8% of the cells that were undergoing apoptotic cell death as characterized by this method in the control cell cultures.
On the basis of the total number of cells quantified in 5 separate fields within each well in response to different treatments, we observed no significant difference (P Ͼ 0.05) in the total number of cells in response to treatments as compared to the controls (data not shown).
Isolation of PR cDNA
To determine whether the PR was expressed in the bovine CL, we utilized the reverse transcription (RT)-PCR technique. The primers employed were based on bovine oviduct PR sequence (accession no. #Z86041) and generated the predicted 380-base pair PCR product. Preliminary restriction analysis based on the known sequence resulted in the predicted fragments, and subsequent sequence analysis (data not shown) showed that the isolated cDNA encoded the bovine PR. The PCR product was evident in bovine CL collected from both pregnant and nonpregnant cows (Fig. 4A) . In addition, we observed the 380-base pair fragment in samples derived from enriched large and small steroidogenic luteal cell fractions obtained by elutriation (Fig. 4A) . There was also evidence of the PR in the ovary, lung, uterus, heart, and kidney (Fig. 4B) . Little if any product was observed in tissue samples derived from the spleen (Fig. 4B) . Furthermore, the partial cDNA isolated from the bovine CL was 100% homologous to that previously isolated from the bovine oviduct (accession no. Z86041) and 89%, 97%, and 88% homologous to that in the human, sheep, and rabbit, respectively (accession nos. M15716, Z66555, M14547).
Immunohistochemical Identification of PR
Immunostaining for PR in bovine CL is depicted in Figure 5 . Specific nuclear staining with JZB-39 was evident in the large luteal cells and was detectable in some of the small luteal cells. No specific nuclear staining was detected by the nonspecific antibody AT. Cytoplasmic staining by JZB-39 was considered to be nonspecific since it was also present in sections treated with AT. Specific nuclear staining for PR was not detected in the endothelial cells of the luteal capillaries or in some of the small luteal cells. Localization of PR immunostaining was similar in the two animals tested; overall, this pattern of JZB-39 staining was identical to that reported previously for the monkey CL [34] .
Treatment with PR Antagonists
To determine whether the anti-apoptotic effect of P 4 was mediated by the PR, luteal cell cultures were treated with RU-486 and onapristone, two known PR antagonists. The addition of RU-486 to bovine luteal cell cultures resulted in an increase in oligonuclesomal DNA fragmentation as compared to that in the vehicle-treated controls (Fig. 6A) . Similar to observations after treatment with RU-486, the addition of onapristone resulted in an increase in apoptotic cell death (Fig. 6B) . We observed no difference (P Ͼ 0.05) in the levels of P 4 in control cultures or cultures (260 Ϯ 33 ng/ml) treated with RU-486 (277 Ϯ 25 ng/ml) or onapristone (248 Ϯ 14 ng/ml) at the 48-h time point.
DISCUSSION
In 1981 Rothchild [10] put forth an interesting hypothesis implicating P 4 as a universal regulator of luteal function. Since that time, evidence has accumulated that supports this concept. LH receptor numbers increase in bovine luteal cell cultures in response to treatment with P 4 [16] . Likewise, the ratio of prostaglandin F 2␣ in relation to prostaglandin E is altered after P 4 supplementation [17] . With the onset of luteal regression there is an increase in luteal apoptotic activity, which is associated with decreased circulating P 4 levels [23, 25] . Therefore, it seems likely that P 4 itself may have anti-apoptotic activity [8] .
Our results suggest that P 4 may directly affect luteal cell apoptosis. Aminoglutethimide, an inhibitor of P450 choles-terol side-chain cleavage, effectively reduced P 4 synthesis and increased oligonucleosomal DNA fragmentation in luteal cell cultures. It is unlikely that the increase in oligonucleosomal DNA fragmentation was due to some toxic effect of aminoglutethimide, since the addition of P 4 to aminoglutethimide-treated cultures inhibited the increase in apoptosis. Our results are consistent with a previous report by Duffy et al. [36] demonstrating that inhibition of luteal P 4 synthesis by the 3␤-hydroxysteroid dehydrogenase inhibitor, trilostane, resulted in lower serum P 4 levels as well as premature luteal regression in the monkey. Those observations were based on histological indices of tissues derived from in vivo studies [36] , whereas our data are based on biochemical parameters of cell death and morphological assessment based on a nuclear stain. Our results support the idea that P 4 may play an active role in the inhibition of luteal regression by a direct effect on the CL.
The mechanism by which P 4 maintains luteal function is unknown. The PR has been identified in primate and sheep luteal tissue [5] ; however, the mechanism or signaling pathway by which P 4 exerts its action on the CL of the domestic species has not been demonstrated. To determine whether or not the action of P 4 is the result of a steroid-receptor interaction, we treated luteal cells with two different PR antagonists. Addition of RU-486 (mifepristone) resulted in an increase in apoptosis. This interaction provided evidence supporting a role for P 4 -initiated luteotropic activity at the receptor level. Onapristone, a more sensitive inhibitor of PR activity, also increased apoptosis in luteal cell cultures, further supporting this concept of steroid ligand-receptor interaction. However, other mechanisms may explain our results. Onapristone and RU-486 have the potential to inhibit glucocorticoid receptors at high levels. In fact, a recent study suggested that in the absence of any conclusive evidence for the presence of PR in the rat CL, P 4 effects are mediated via the glucocorticoid receptor [29] . On the basis of the relatively low concentrations of PR antagonists used in this study and our demonstration of PR mRNA in bovine luteal cells, we do not feel that the P 4 or the PR antagonists are working via the glucocorticoid receptor. Additional experiments will be required to determine whether or not the glucocorticoid receptor is involved in bovine luteal cell death. Additionally, recent evidence suggests that P 4 may act via nonclassical receptor target sites by binding to the plasma membrane [28] . Regardless of the exact mechanism, our results clearly demonstrate that removal of P 4 and treatment with antagonists of PRs lead to apoptosis in vitro.
Our data demonstrate that the message encoding the PR is present in the bovine CL, which is similar to the human, monkey, and pig CL. In contrast, the PR is not present in the rat CL and is only transiently expressed in the follicle just prior to ovulation [29] . Given the fact that the bovine CL is composed of steroidogenic and nonsteroidogenic cells [37, 38] , it was necessary to consider whether or not specific cell types within the CL express the PR. Previous evidence in the primate has shown that the PR is present in the steroid-producing cells of the CL [6, 12, 13, 39, 40] . We initially hypothesized that P 4 itself may somehow regulate P 4 synthesis in the large cell. Given the anti-apoptotic nature of P 4 , if P 4 is signaling via the large luteal cell, this may in part explain why the large luteal cells succumb sequentially to the apoptotic process after the nonsteroidogenic and small luteal cells undergo their demise during luteal regression [24] . The present study, however, demonstrates that PR mRNA is expressed in both the large and small steroidogenic cells of the bovine CL. These data must be interpreted with caution, for it is well known that although the steroidogenic cell fractions are relatively pure, the potential for limited contamination exists. Nevertheless, the abundance of the fragment observed following PCR suggests that the PR message is expressed in both cell types. Previous immunohistochemical studies in the monkey indicated that not all luteal cells demonstrating positive staining for 3␤-hydroxysteroid dehydrogenase stained positive for the PR [12] . This is further supported by our results, which provide evidence that although the PR is present in luteal cells during midluteal phase, not all steroidogenic luteal cells express the PR. On the basis of our data with a limited number of samples, the majority of the PRpositive cells appeared to be of the large luteal cell subtype. The physiological ramifications of this phenomenon are yet to be investigated. Thus, by inhibiting P 4 synthesis in the CL or luteal tissue, the increase in cell death may be limited to those cells that express the PR. This may explain, in part, the limited increase in apoptosis associated with P 4 removal or PR antagonists. In addition, the modest increases in low molecular weight DNA laddering observed in response to PR antagonists may be due in part to an underestimation of total cell death. In the methodology used in this study, only those cells remaining adhered to the culture dishes were analyzed. Further studies are needed to characterize those specific populations of luteal cells expressing the PR and undergoing apoptosis. Likewise, characterizing the PR subtype expressed throughout the estrous cycle may help us to understand the role of P 4 in luteal cell fate.
